Day: January 6, 2023

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting)December 31, 2022 20 455 403 250 392 22 948 713 22 698 321November 30, 2022 20 455 403 177 280 23 012 201 22 834 921October 31, 2022 20 455 403 145 022 23 048 421 22 903 399September 30, 2022 20 455 403 90 180 23 050 521 22 960 341August 31, 2022 20 455 403 83 843 23 050 522 22 966 679July 31, 2022 20 455 403 82 029 23 050 622 22 968 593July 2, 2022 (***) 20 455 403 78 771 23 050...

(Oslo, Norway – January 6, 2023) Hydrogen technology company Nel and Europe’s largest supplier of renewable energy, Statkraft, newly signed a contract for delivery of 40 MW electrolysers and will thus collaborate to create a strong value chain for production of green hydrogen in Norway. “We are determined that we will contribute towards making Norway a leading producer of renewable hydrogen, and to establish an eco-system of electrolyser and equipment suppliers,” says Nel’s CEO Håkon Volldal and CEO of Statkraft, Christian Rynning-Tønnesen. The announcement was made in connection with the German Vice Chancellor Robert Habeck’s visit to Nel’s fully automated electrolyser manufacturing facility at Herøya in Norway. The Norwegian Minister of Trade and Industry, Jan Christian Vestre, is also joining the delegation together with his colleague,...

VANCOUVER, British Columbia, Jan. 06, 2023 (GLOBE NEWSWIRE) — Asante Gold Corporation (“Asante” or the “Company” CSE:ASE | GSE:ASG | FRANKFURT:1A9 | U.S.OTC:ASGOF) today disclosed that it has formed an executive committee of the Board (the “Executive Committee”) and engaged advisors to protect the interests of all shareholders against a group of dissident shareholders (the “Dissidents”). The Executive Committee believes that the Dissidents are promoting their own interests, and that some may have obtained confidential information about Asante that is not available to all shareholders. Shareholders are cautioned to take no steps in relation to matters which may be raised by the Dissidents. The formation of the Executive Committee follows an unsuccessful stealth proxy solicitation campaign (the “Stealth Campaign”) in advance of the...

Hermed følger den forventede finanskalender for Investeringsforeningen PFA Invest i 20231. februar 2023  Frist for fremsættelse af forslag til behandling på den ordinære generalforsamling10. februar 2023  Offentliggørelse af årsrapport for 202229. marts 2023  Ordinær generalforsamling30. august 2023     Offentliggørelse af halvårsrapport for første halvår 2023Eventuel henvendelse vedrørende denne meddelelse kan rettes til Sine Brandt på sib@pfa.dk.Med venlig hilsenPFA Asset Management A/S

In December 2022, the number of Icelandair’s passengers was 233,500, compared to 168,500 in December 2021. Total number of passengers in 2022 reached around 3.7 million, compared to 1.5 million in 2021, an increase of 150% between years. In 2022 capacity has steadily increased, reaching 91% of the 2019 capacity in December, compared to 53% in January 2022 and 77% in June. In December, the number of passengers on international flights was 214 thousand compared to 149 thousand in December 2021. The number of passengers to Iceland was 79 thousand and from Iceland around 50 thousand. Via passengers were 85 thousand. On time performance on international flights was 62.4%. Load factor on international flights was 73%, compared to 71% in December 2021. On time performance, load factor and the overall operation was significantly affected by disruptions...

HAMILTON, Ontario, Jan. 06, 2023 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has added 34 new acute and long-term care hospital clients to a previously disclosed contract with a large healthcare network in Florida. These new clients are expected to add over 20,000 patients per year to Reliq’s iUGO Care platform at an average revenue of $65 per patient per month. The Company also wishes to invite shareholders to attend a webinar on Wednesday, January 11, 2023 at 9:00am PST / 12:00pm EST, where the Company will provide an update on operations and discuss the outlook for 2023. “The...

In 2022, 7 million passengers and 18 million tonnes of cargo passed through the harbours of Tallinna Sadam. The annual number of passengers increased by 98%, or 3.5 million passengers, recovering from the movement restrictions related to the pandemic. Compared to last year, the cargo volume decreased by 21%, or 4.6 million tons, due to the implementation of sanctions on Russian and Belarussian cargo. The decline in liquid bulk and dry bulk volumes due to sanctions was somewhat offset by growth in all other cargo types. The number of vessel calls was relatively stable, decreasing by only 2% to 7,130 visits. The number of passengers between the Estonian mainland and the main islands recovered increased by 4%. The number of charter days of the icebreaker Botnica decreased by 7% due to the shorter charter period of the Canadian project in...

If approved, glofitamab would be the first fixed-duration CD20xCD3 T-cell engaging bispecific antibody approved to treat the most aggressive type of non-Hodgkin lymphoma Results from the pivotal phase I/II NP30179 study showed glofitamab induced durable response rates in people with heavily pre-treated large B-cell lymphoma, with 40% achieving a complete response Glofitamab is part of Roche’s industry-leading portfolio of T-cell engaging bispecific antibodies, which also includes the newly FDA-approved first-in-class Lunsumio to treat follicular lymphomaBasel, 6 January 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) and granted priority review for glofitamab, an investigational CD20xCD3 T-cell engaging bispecific...

Revenue growth +20.2% Organic revenue growth +12.3%Issy-les-Moulineaux, January 6, 2023 Sodexo (NYSE Euronext Paris FR 0000121220-OTC: SDXAY). Q1 Fiscal 2023 revenuesREVENUES(in millions of euros) Q1 FY23 Q1 FY22 ORGANIC GROWTH EXTERNAL GROWTH CURRENCY EFFECT TOTAL GROWTHNorth America 2,992 2,205         +15.7%         +1.1%         +18.8%         +35.7%Europe 2,047 2,023         +5.9%         -3.6%         -1.1%         +1.2%Rest of the World 1,057 854         +15.3%         -1.9%         +10.4%         +23.9%On-Site Services 6,097 5,082         +11.9%         -1.2%         +9.3%         +20.0%Benefits & Rewards Services 234 183         +23.4%         -1.6%         +6.4%         +28.2%Elimination (1) (1)        TOTAL GROUP 6,330 5,264         +12.3%         -1.2%         +9.2%         +20.2%Commenting...